Europe 1 with AFP 12:59 p.m., September 20, 2021, modified at 12:59 p.m., September 20, 2021
According to the results of a study announced Monday by Pfizer and BioNTech, the vaccine against the coronavirus developed by these two laboratories is "safe" and "well tolerated" by children aged 5 to 11.
The right dosage triggers a "robust" immune response in these young people.
The Pfizer / BioNTech vaccine against Covid-19 is "safe" and "well tolerated" by children aged 5 to 11 and the right dosage triggers a "robust" immune response, according to the results of a study announced Monday by the laboratories.
The two companies plan to submit this data to the authorities "as soon as possible", according to a statement, which specifies that the immune reaction was "comparable" to that observed in 16 to 25 year olds who received a higher dose vaccine.
>> More information to follow